CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Harbin Gloria Pharmaceuticals Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Harbin Gloria Pharmaceuticals Co., Ltd.
Building 28, Ronghuiyuan
Yuhua Road
Phone: +86 1080479607p:+86 1080479607 BEIJING, BEJ  101318  China Ticker: 002437002437
Business Summary
HARBIN GLORIA PHARMACEUTICALS Co., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's products include cardiovascular and cerebrovascular drugs, orthopedic drugs, nutritional drugs, anti-infective drugs, immune-enhancing drugs, diabetes drugs, antineoplastic drugs and electrolytes drugs. The Company is also engaged in the agency, research and development of pharmaceuticals, the provision of clinical services and financial investment business. The Company distributes its products within domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JinHu 46 12/4/2022 11/11/2022
Vice Chairman of the Board DongxuWang 59 6/1/2008 6/1/2008
Finance Director, General Manager, Director LeifengGuo 50 1/15/2024 9/9/2014
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Shanxi Pude Pharmaceutical Co Ltd No.55 Hubin Street DATONG SHX China

Business Names
Business Name
002437
Shanxi Pude Pharmaceutical Co Ltd

General Information
Number of Employees: 3,085 (As of 12/31/2023)
Outstanding Shares: 2,270,513,950 (As of 3/12/2024)
Shareholders: 101,802
Stock Exchange: SHE
Fax Number: +86 1068002438


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024